Schedule 13G ownership disclosure

Soleno Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 834203309

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vivo Opportunity Fund Holdings, L.P.

    Shares: 3,958,294.00 · Class: 7.4%

  • Vivo Opportunity, LLC

    Shares: 3,958,294.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-075188
Form type
SCHEDULE 13G/A
Filer
SOLENO THERAPEUTICS INC
CIK
CIK 1484565
Filed
Aug 12, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub